Fennec Pharmaceuticals (FENC) Net Income towards Common Stockholders (QoQ) (2010 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 442.38% |
| Sep 30, 2025 | 80.25% |
| Jun 30, 2025 | -171.05% |
| Mar 31, 2025 | 22.45% |
| Dec 31, 2024 | 73.72% |
| Sep 30, 2024 | -3.59% |
| Jun 30, 2024 | -142.72% |
| Mar 31, 2024 | 592.97% |
| Dec 31, 2023 | -47.83% |
| Sep 30, 2023 | 67.06% |
| Jun 30, 2023 | 9.78% |
| Mar 31, 2023 | 11.40% |
| Dec 31, 2022 | 15.86% |
| Sep 30, 2022 | -58.08% |
| Jun 30, 2022 | -40.67% |
| Mar 31, 2022 | 15.53% |
| Dec 31, 2021 | -0.97% |
| Sep 30, 2021 | -7.61% |
| Jun 30, 2021 | 20.24% |
| Mar 31, 2021 | -47.34% |
| Dec 31, 2020 | 42.90% |
| Sep 30, 2020 | -20.90% |
| Jun 30, 2020 | -27.05% |
| Mar 31, 2020 | -6.03% |
| Dec 31, 2019 | -99.89% |
| Sep 30, 2019 | 61.88% |
| Jun 30, 2019 | -79.92% |
| Mar 31, 2019 | 12.58% |
| Dec 31, 2018 | -8.85% |
| Sep 30, 2018 | -5.98% |
| Jun 30, 2018 | -49.65% |
| Mar 31, 2018 | 30.50% |
| Dec 31, 2017 | -14.84% |
| Sep 30, 2017 | -47.22% |
| Jun 30, 2017 | -91.93% |
| Mar 31, 2017 | 32.87% |
| Dec 31, 2016 | -103.92% |
| Sep 30, 2016 | 20.31% |
| Jun 30, 2016 | -55.07% |
| Mar 31, 2016 | 17.60% |
| Dec 31, 2015 | -63.50% |
| Sep 30, 2015 | 39.61% |
| Jun 30, 2015 | -23.73% |
| Mar 31, 2015 | 42.91% |
| Dec 31, 2014 | -27.63% |
| Sep 30, 2014 | 33.51% |
| Jun 30, 2014 | -72.73% |
| Mar 31, 2014 | -29.26% |
| Dec 31, 2013 | -717.65% |
| Sep 30, 2013 | 94.52% |
| Jun 30, 2013 | -73.83% |
| Mar 31, 2013 | 51.85% |
| Dec 31, 2012 | -77.76% |
| Sep 30, 2012 | 49.88% |
| Jun 30, 2012 | -105.10% |
| Mar 31, 2012 | 31.53% |
| Dec 31, 2011 | 3.79% |
| Sep 30, 2011 | -61.08% |
| Jun 30, 2011 | 43.32% |
| Mar 31, 2011 | -25.59% |
| Dec 31, 2010 | 10.95% |
| Sep 30, 2010 | 63.80% |